Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)
BenzingaNov 12 01:45
Ladenburg Thalmann Maintains Buy on NovaBay Pharmaceuticals, Lowers Price Target to $3.8
BenzingaAug 11, 2023 23:06
No Data